MedPath

University of Alberta

University of Alberta logo
🇨🇦Canada
Ownership
Private
Established
1908-01-01
Employees
10K
Market Cap
-
Website
http://www.ualberta.ca

Extension of the 5As Team Study for Improved Provider Obesity Management to Physicians and Medical Trainees (Part 2)

Completed
Conditions
Obesity
First Posted Date
2016-01-07
Last Posted Date
2018-02-23
Lead Sponsor
University of Alberta
Target Recruit Count
75
Registration Number
NCT02648308
Locations
🇨🇦

University of Alberta - Department of Family Medicine, Edmonton, Alberta, Canada

Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors

Not Applicable
Completed
Conditions
Head and Neck Neoplasms
Fatigue
Accessory Nerve Injury
Interventions
Behavioral: Therapeutic Exercise
Behavioral: Therapeutic + Lower Body Exercise
First Posted Date
2016-01-06
Last Posted Date
2024-01-03
Lead Sponsor
University of Alberta
Target Recruit Count
60
Registration Number
NCT02647021
Locations
🇨🇦

University of Alberta/ Cross Cancer Institute, Edmonton, Alberta, Canada

Asthma Exacerbations and Vascular Function

Not Applicable
Completed
Conditions
Asthma
Interventions
Drug: Mannitol
Drug: Methacholine
Drug: Placebo
Other: Rest
Other: Exercise
First Posted Date
2015-12-15
Last Posted Date
2021-07-01
Lead Sponsor
University of Alberta
Target Recruit Count
52
Registration Number
NCT02630511
Locations
🇨🇦

Clinical Physiology Research Laboratory, Edmonton, Alberta, Canada

Novel vs. Traditional US Diaphragm Scanning

Not Applicable
Terminated
Conditions
Respiratory Diaphragm
Interventions
Other: Diaphragm scanning - novel method first
Other: Diaphragm scanning - traditional method first
First Posted Date
2015-12-01
Last Posted Date
2020-03-25
Lead Sponsor
University of Alberta
Target Recruit Count
100
Registration Number
NCT02617394
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

Chest Pressure for Intubated Peds Patients

Not Applicable
Withdrawn
Conditions
Noninvasive Ventilation
Interventions
Procedure: Gentle chest pressure
First Posted Date
2015-11-26
Last Posted Date
2020-03-25
Lead Sponsor
University of Alberta
Registration Number
NCT02615834
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy

Phase 4
Completed
Conditions
Depressive Disorder
Interventions
Drug: Placebo
Drug: Ketamine
First Posted Date
2015-10-19
Last Posted Date
2021-04-28
Lead Sponsor
University of Alberta
Target Recruit Count
48
Registration Number
NCT02579642
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

🇨🇦

Alberta Hospital Edmonton, Edmonton, Alberta, Canada

Infant Nasal Nitric Oxide Levels in Congenital Heart Disease

Not Applicable
Terminated
Conditions
Congenital Heart Disease
Interventions
Device: Measurement of nasal Nitric Oxide level
First Posted Date
2015-09-16
Last Posted Date
2018-01-24
Lead Sponsor
University of Alberta
Target Recruit Count
67
Registration Number
NCT02551107
Locations
🇨🇦

Stollery Children's Hospital, Edmonton, Alberta, Canada

Levothyroxine Treatment for Subclinical Hypothyroidism After Head and Neck Surgery

Phase 2
Withdrawn
Conditions
Hypothyroidism
Neoplasms
Postoperative Complications
Interventions
Drug: Placebo
Drug: Levothyroxine
First Posted Date
2015-09-14
Last Posted Date
2022-07-13
Lead Sponsor
University of Alberta
Registration Number
NCT02548715

A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia

Phase 1
Withdrawn
Conditions
Leukemia, Myelomonocytic, Acute
Leukemia, Myeloid, Acute
Leukemia, Monocytic, Acute
Leukemia, Erythroblastic, Acute
Leukemia, Megakaryoblastic, Acute
Interventions
First Posted Date
2015-08-18
Last Posted Date
2017-04-05
Lead Sponsor
University of Alberta
Registration Number
NCT02527174
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

🇨🇦

Tom Baker Cancer Centre, Calgary, Alberta, Canada

Aralast NP in Islet Transplant

Phase 1
Completed
Conditions
Type 1 Diabetes Mellitus
Interventions
Drug: Alpha-1 Antitrypsin
First Posted Date
2015-08-11
Last Posted Date
2022-05-24
Lead Sponsor
University of Alberta
Target Recruit Count
5
Registration Number
NCT02520076
Locations
🇨🇦

University of Alberta, Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath